Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments

Int J Mol Sci. 2021 Jul 31;22(15):8271. doi: 10.3390/ijms22158271.

Abstract

There is a need for new, safer, and more effective agents to treat cancer. Cytostatics that have transition metals at their core have attracted renewed interest from scientists. Researchers are attempting to use chemotherapeutics, such as cisplatin, in combination therapy (i.e., in order to enhance their effectiveness). Moreover, studies are being carried out to modify molecules, by developing them into multinuclear structures, linking different compounds to commonly used drugs, or encapsulating them in nanoparticles to improve pharmacokinetic parameters, and increase the selectivity of these drugs. Therefore, we attempted to organize recent drug findings that contain palladium and platinum atoms in their structures.

Keywords: anticancer treatments; palladium complexes; platinum complexes.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic
  • Drug Synergism
  • Humans
  • Neoplasms / drug therapy*
  • Organoplatinum Compounds / chemistry*
  • Organoplatinum Compounds / pharmacology
  • Organoplatinum Compounds / therapeutic use
  • Palladium / chemistry*

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Palladium